Some people on weight loss drugs may be able to get them at a much lower cost next year after President Trump announced a new deal on Thursday with the drug makers of certain GLP-1s.
Breakdown
- President Trump announced a deal with Eli Lilly and Novo Nordisk to lower weight loss drug prices. 7s
- Under the plan, Wegovy's lowest dose will start at $245/month and Zepbound's at $149/month. 24s
- Eligibility for lower-cost drugs includes Medicare patients with pre-diabetes, stage 3 kidney disease, or severe obesity. 1m 10s
- The initiative is part of efforts to use Medicare and Medicaid's purchasing power to reduce drug costs. 1m 34s
- A federal judge ordered the administration to pay full SNAP benefits for November, impacting 42 million Americans. 1m 51s